| In transgenic mice programmed to express both mutant oncogenes in the lung epithelium, the resulting tumors express either the KRAS, or the EGFR oncogene. | lung, |
| Evidence that synthetic lethality underlies the mutual exclusivity of oncogenic KRAS and EGFR mutations in lung adenocarcinoma. | lung, |
| KIF5B-RET Fusion gene may coincide oncogenic mutations of EGFR or KRAS gene in lung adenocarcinomas. | lung, |
| These findings suggest that ezrin-EGFR interaction augments oncogenic functions of EGFR and that targeting ezrin may provide a potential novel approach to overcome erlotinib resistance in non-small cell lung cancer cells | lung, |
| miR-875-5p played a pivotal role in colorectal carcinoma through inhibiting cell proliferation, migration, invasion, and promoting apoptosis by targeting oncogenic EGFR | colorectal, |
| EGFR-induced DNA methylation-mediated transcriptional silencing of tumor suppressors may have therapeutic benefits for oncogenic EGFR-mediated lung cancers and glioblastomas. | glioblastoma,lung, |
| EGFR and C/EBP-beta oncogenic signaling is bidirectional in human glioma and varies with the C/EBP-beta isoform | glioma, |
| Oncogenic activation of EGFRwt in GBM is likely maintained by a continuous EGFL7 autocrine flow line. | GBM, |
| Amplification of the c-erb B1 oncogene in chemically-induced oral carcinomas. | oral |
| Overexpression of N-ras oncogene and epidermal growth factor receptor gene in human glioblastomas. | glioblastoma, |
| In EGFR-mutant oncogene-addicted cells, blocking TNF enhances the effectiveness of EGFR inhibition. EGFR plus TNF inhibition is also effective in NSCLC with acquired resistance to EGFR inhibition. | lung, |
| EGFR-mutant non-small cell lung cancer(NSCLC) is incurable despite the marked sensitivity of these tumors to EGFR TKIs. These findings identify N-linked glycosylation, a posttranslational modification common to EGFR and other oncogenic signaling proteins, as an effective therapeutic target that enhances tumor responses for EGFR-mutant NSCLC | lung, |
| A tumor-suppressive role of miR-1296-5p through the translational repression of oncogenic CDK6 and EGFR in gastric cancer. | gastric, |
| [Immunohistochemical studies on epidermal growth factor receptor and the myc oncogene product in squamous cell carcinoma of the uterine cervix]. | uterine, |
| Expression of epidermal growth factor receptor proto-oncogene mRNA in regenerating rat liver. | liver, |
| Polysomy of chromosome 7 is correlated with overexpression of the erbB oncogene in human glioblastoma cell lines. | glioblastoma, |
| Oncogene proteins and proliferation antigens in thymomas: increased expression of epidermal growth factor receptor and Ki67 antigen. | thymoma, |
| [Amplification of C-erB-2 oncogene in colon carcinomas]. | colorectal, |
| C-erb-B-2 oncoprotein and epidermal growth factor receptor in human hepatocellular carcinoma: an immunohistochemical study. | liver, |
| Expression of HER-2/neu oncoprotein and epidermal growth factor receptor and prognosis in gastric carcinoma. | gastric, |